Coronary Risk Factors: Pocketbook: Measurement and Management
Coronary heart disease is the single most important cause of death in our society, incurring enormous costs both in human and financial terms. The underlying disease process is atherosclerosis, an inflammatory response to endothelial injury. Fortunately, pharmaceutical products for lipid-lowering and coronary artery stents are available to cardiologists in order to produce a reversal, a regression of atherosclerotic disease, thus helping to lower the rates for sudden death, myocardial infarction and angina pectoris. The authors neatly summarize all coronary risk factors and treatments to reduce them.
What people are saying - Write a review
We haven't found any reviews in the usual places.
25 per cent Adapted angina atheromatous plaque atheroscler atherosclerosis benefit blood flow blood pressure British Regional Heart cardiovascular disease CHD death CHD event CHD mortality rates CHD prevention Cholesterol mmol/l cholestyramine cigarette coronary heart disease developing CHD Diastolic Diastolic BP dyslipidaemia effects endothelial factors for CHD family history fatty streak Figure Framingham Gemfibrozil Health High density lipoprotein HMSO hypercholesterolaemia hypertension incidence of CHD increased risk individual Kannel WB Lancet LDL cholesterol lesion lifestyle modification lipid lipid lowering drug Lipid Research Clinics LlPlD ltaly middle-aged mmHg Multiple Risk Factor non-fatal Ml Non-Smokers patients with established placebo pravastatin pravastatin therapy primary prevention randomized reduction Regional Heart Study regression revascularization risk factors risk of CHD risk of developing risk spectrum Scandinavian Simvastatin Survival secondary prevention serum cholesterol Simvastatin Simvastatin Survival Study Society stopping smoking stroke thrombus total mortality total plasma cholesterol triglyceride women WOSCOPS